We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 35% below its sector, cheaper than its peers on earnings.
Established in 1993 and headquartered in Zhuzhou, China, ZhuZhou QianJin Pharmaceutical Co.,Ltd operates as a leading manufacturer and distributor of pharmaceutical goods throughout China. The company boasts a comprehensive product portfolio, encompassing treatments for women's health, pediatric ailments, dermatological concerns, anti-infectives, and conditions affecting the circulatory, endocrine, digestive, nervous, and cardiovascular systems. Additionally, they offer specialized medications and traditional Chinese remedies. These diverse pharmaceutical offerings are presented in various formats, including pills, tablets, capsules, granules, powders, decoctions, and liquid solutions. Beyond its core pharmaceutical business, ZhuZhou QianJin also produces ginger-based beverages, feminine hygiene products, and alcoholic beverages.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 600479.SS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
